HEA 1.2 BEADCHIP TEST KIT
Report
- Report Number
- 3005967741-2023-00001
- Event Type
- Malfunction
- Date Received
- May 1, 2023
- Date of Event
- April 3, 2023
- Report Date
- October 9, 2023
- Manufacturer
- BIOARRAY SOLUTIONS, LIMITED
- Product Code
- MAO
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
UPDATE 09OCT2023: THE SEQUENCING RESULT DETERMINED THAT THE MOLECULAR PRESENCE OF CYTOSINE AT THE POLYMORPHIC SITE C.307C AND GUANINE AT THE POLYMORPHIC SITE C.676G ARE INDICATIVE OF RHC(+), RHE(+) ANTIGENS1 FROM THE RHCE*01 (RHCE*CE) ALLELE, WHICH ARE CONSISTENT WITH THE SEROLOGY TYPING AND PHENOTYPES FROM THE RHCE BEADCHIP. THE RHC(+) IN SEQUENCING IS DISCORDANT WITH RHC(0) IN HEA 1.2 BEADCHIP, WHICH IS LIKELY DUE TO THE INTERFERING C.150A IN THE RHCE EXON 2 PRIMER BINDING REGION FROM THE FORWARD SEQUENCING READ AND IT IS ABSENT IN THE REVERSE SEQUENCING READ. THE SEQUENCING INVESTIGATION ALSO IDENTIFIES SIMILAR INTERFERENCE OF C.180A FOR C.180T IN THE EXON 2 OF THE RHCE GENE. PRESENCE OF THE UNANTICIPATED MUTATION IN THE PRIMER REGION COULD RESULT IN THE FALSE NEGATIVE CALL, WHICH IS LISTED AS A LIMITATION OF THE HEA 1.2 BEADCHIP PACKAGE INSERT.
OUR TECHNICAL SUPPORT TEAM IN FRANCE RECEIVED A COMPLAINT FOR DISCREPANCY OF RESULTS BETWEEN HEA 1.2 BEADCHIP SLIDE KIT AND RHCE KIT. THERE IS A DISCORDANCE IN THE RHC ANTIGEN. UPDATE 09OCT2023: THE TEST REPORT WAS PROVIDED TO BIOARRAY FOR REVIEW, AND IT WAS CONFIRMED THAT THE PATIENT DONOR TYPE C POSITIVE (+) WITH RHCE/SEROLOGY AND C NEGATIVE (-) WITH HEA 1.2 BEADCHIP.
OUR TECHNICAL SUPPORT TEAM IN FRANCE RECEIVED A COMPLAINT FOR DISCREPANCY OF RESULTS BETWEEN HEA 1.2 BEADCHIP SLIDE KIT AND RHCE KIT. THERE IS A DISCORDANCE IN THE RHC ANTIGEN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 827214 | HEA 1.2 BEADCHIP TEST KIT | HEA BEADCHIP KIT | MAO | BIOARRAY SOLUTIONS, LIMITED | 800-10202-08 | 22-15-C |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown |